Skip to content
10-Q

Quarterly Report

Comera Life Sciences Holdings, Inc.

0000950170-23-021812

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 11, 2023 22.31M sh
Shares Diluted Q1 2023 · Mar 31, 2023 19.03M sh
Shares Diluted Q1 2023 · Mar 31, 2022 718.42K sh
Capex Q1 2023 · Mar 31, 2023 $88.36K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$1.91M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$2.87M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $1.54M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $446.61K
Cash And Equivalents Q1 2023 · Mar 31, 2022 $3.86M
Stockholders Equity Q1 2023 · Mar 31, 2023 −$5.26M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$6.25M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$17.09M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$14.69M
Current Liabilities Q1 2023 · Mar 31, 2023 $3.36M
Current Liabilities Q1 2023 · Dec 31, 2022 $5.06M
Total Liabilities Q1 2023 · Mar 31, 2023 $3.66M
Total Liabilities Q1 2023 · Dec 31, 2022 $5.46M
Current Assets Q1 2023 · Mar 31, 2023 $2.41M
Current Assets Q1 2023 · Dec 31, 2022 $3.06M
Total Assets Q1 2023 · Mar 31, 2023 $3M
Total Assets Q1 2023 · Dec 31, 2022 $3.73M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.13
Eps Diluted Q1 2023 · Mar 31, 2022 −$4.01
Eps Basic Q1 2023 · Mar 31, 2023 −$0.13
Eps Basic Q1 2023 · Mar 31, 2022 −$4.01
Sga Expense Q1 2023 · Mar 31, 2023 $2.43M
Sga Expense Q1 2023 · Mar 31, 2022 $2.02M
Rd Expense Q1 2023 · Mar 31, 2023 $343.71K
Rd Expense Q1 2023 · Mar 31, 2022 $487.22K
Net Income Q1 2023 · Mar 31, 2023 −$2.48M
Net Income Q1 2023 · Mar 31, 2022 −$2.88M
Operating Income Q1 2023 · Mar 31, 2023 −$2.5M
Operating Income Q1 2023 · Mar 31, 2022 −$2.45M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $116.52K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $44.52K
Revenue Q1 2023 · Mar 31, 2023 $392.92K
Revenue Q1 2023 · Mar 31, 2022 $95.33K
Short Term Debt Q1 2023 · Dec 31, 2022 $455.56K